Pricing Log in Create free account

Turn Therapeutics Inc. (TTRX) vs Vogenx Inc (VOGX)

Turn Therapeutics Inc. and Vogenx Inc are both Biotechnology companies. Turn Therapeutics Inc. and Vogenx Inc are of similar size ($273.0M and $270.8M). Across the 3 metrics below, Vogenx Inc leads on 2 and Turn Therapeutics Inc. on 1.

Valuation

Metric TTRX VOGX Biotechnology median
P/E n/m — 10.60
P/S n/m n/m 9.40
P/B 403.30 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (3.12%) — (32.88%)
Free cash flow yield (1.61%) 0.00% (23.13%)

Profitability

Metric TTRX VOGX Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity (3,315.33%) — (51.96%)
Return on assets (99.59%) — (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric TTRX VOGX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (80.72%) — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric TTRX VOGX Biotechnology median
Debt to equity 8.83 0.00 0.00
Current ratio 1.19 0.44 4.97
Net debt to EBITDA 0.96 — 1.01

Dividend

Metric TTRX VOGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric TTRX VOGX Biotechnology median
Market cap 272.96m 270.81m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack